The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Perfect Slim Fast Track Slim, a product promoted for weight loss.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Slyn Both, a product promoted for weight loss.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Super Herbs, a product promoted for weight loss on the website, www.mysuperherbs.com , and in some retail stores.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use SPCARET Princess Diet, a product promoted for weight loss.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Rhino X, a product promoted for sexual enhancement.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Zero Fat, a product promoted for weight loss.

Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose.

The U.S. Food and Drug Administration, in partnership with other government agencies, today announced the results of a yearlong sweep of dietary supplements to identify potentially unsafe or tainted supplements.